Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
ADC Therapeutics Ltd
ADCT
$
27.51
-0.69%
Mon October 12th, 2020
06:05
Analysis
Genmab: Still A Rising Star In Biotech, But Legal Dispute May Slow Down Growth Trajectory In The Near Term
Seeking Alpha
Wed August 19th, 2020
00:48
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Earnings
Analysis
ADC Therapeutics SA (ADCT) CEO Christopher Martin on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Sun July 19th, 2020
17:44
Analysis
Karyopharm's XPOVIO Progress And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha
Tue July 7th, 2020
10:26
Analysis
Immunomedics Positive Cancer Data, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha
+ 1 more
Tue June 30th, 2020
14:40
IPO
Press Releases
New Ventures Portfolio Company, ADC Therapeutics, Completes $267 Million IPO
PR Newswire
Sat June 6th, 2020
12:36
Analysis
Stocks To Watch: Buzz On Vroom, Lululemon, GameStop And Sports Betting Plays
Seeking Alpha
